LUBIPROSTONE: A NOVEL DRUG TO TREAT CONSTIPATION

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2013, Vol 1, Issue 2

Abstract

Lubiprostone, a bicyclic fatty acid, is a novel drug of new class of agents called prostones. It is approved by US FDA for the treatment of chronic constipation and constipation associated irritable bowel syndrome (IBS-C). It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit and improve symptoms of constipation. Lubiprostone is well tolerated in majority of the patients with nausea being the most common adverse effect. Lubiprostone represents a new approach of treatment in cases of resistant or intolerable cases of chronic constipation with proven efficacy and safety.

Authors and Affiliations

Kamlesh Garg*| Assistant Professor, Department of Pharmacology, VMMC and Safdarjung Hospital, New Delhi, Surinder Kumar| Medical officer, Department of Anesthesia, VMMC and Safdarjung Hospital, New Delhi, Ruchika Nanda| Assistant Professor, Department of Pharmacology, Dr HSJ Institute of Dental Sciences, Panjab University, Chandigarh, Suraj B| Junior Resident, Department of Pharmacology, VMMC and Safdarjung Hospital, New Delhi

Keywords

Related Articles

Solvent evaporation as a imposing method for microencapsulation - A review

Microencapsulation is a process from which solid, liquid or even gaseous particles are coated with a continuous film of polymeric material, having a diameter in range of 1 to 1000 μm and are widely used as drug carriers....

STUDY THE EFFECT OF CO SOLVENT ON THE SOLUBILITY OF A SLIGHTLY WATER SOLUBLE DRUG

The solubility of a drug depends upon the solvent. Hydrophilic drug are soluble in hydrophilic solvent while hydrophobic drugs are soluble in hydrophobic solvent, sometimes drugs contain both hydrophilic and hydrophobic...

Pharmacognostical and pharmacological evaluation of the leaf of Gmelina Arborea Roxb

Gmelina Arborea Roxb. (Verbenaceae ) is commonly known as gambhari. Gambhari is one of the herbs mentioned in all ancient scriptures of Ayurveda, as one of the member of brhat pancamulas. Acarya Vagbhata has cited gambha...

ESTIMATION OF CHLOROPHYLL CONTENT IN LEAVES OF SOME MEDICINAL PLANTS OF GENUS SESBANIA

The seasonal variation of chlorophyll a, chlorophyll b and carotenoid have been investigated in leaves of Sesbania rostrata, Sesbania exaltata and Sesbania sesban are important medicinal plants. Comparative account of ch...

ORAL SUSTAINED RELEASE DOSAGE FORM: A REVIEW

Oral drug delivery system is the most prominent and convenient route of administration of drugs.The maintenance of concentration of drug in plasma within therapeutic index is very critical for effective treatment. Factor...

Download PDF file
  • EP ID EP1345
  • DOI -
  • Views 729
  • Downloads 53

How To Cite

Kamlesh Garg*, Surinder Kumar, Ruchika Nanda, Suraj B (2013). LUBIPROSTONE: A NOVEL DRUG TO TREAT CONSTIPATION. Journal of Drug Discovery and Therapeutics, 1(2), 1-4. https://www.europub.co.uk/articles/-A-1345